Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-05
1996-09-24
Owens, Amelia
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C07D49304
Patent
active
055592503
ABSTRACT:
Novel compounds for photodecontaminating biological material which are compatible with clinical testing, in that they do not interfere with serum analytes.
REFERENCES:
patent: 3819270 (1974-06-01), Hirschfeld
patent: 4107182 (1978-08-01), Liebman et al.
patent: 4147703 (1979-04-01), Liebman et al.
patent: 4150042 (1979-04-01), Liebman et al.
patent: 4182750 (1980-01-01), Sullivan et al.
patent: 4252653 (1981-02-01), Beck et al.
patent: 4370344 (1983-01-01), Kaufman
patent: 4683195 (1987-07-01), Mullis
patent: 4683202 (1987-07-01), Mullis
patent: 4727027 (1988-02-01), Wiesehahn et al.
patent: 4748120 (1988-05-01), Wiesehahn
patent: 4970230 (1990-11-01), Foupil
patent: 5473083 (1995-12-01), Hiendel et al.
Resnick, et al., Human T-cell lymphotrophic viruses: Synctia Formation, JAMA 255:1887 (1986).
Update: HIV Infections in health-care workers exposed to blood of infected patients; Morbidity and Mortality Weekly Report 36:285 (1987).
Dodd, R. Y. "Will Blood Products be free of infectious agents?" Transfusion Medicine in the 1990's American Association Blood Banks (1990).
Surgenor, D. M. et al., "Red cell transfusions in coronary artery bypass surgery (DRFs 106 and 107)," Transfusion 32:458-464 (1992).
Wallace, E. L., et al, "Collection and transfusion of blood and blood components in the United States, 1989", Transfusion 33:139-144 (1993).
"How Safe Is Our Blood" , U.S. News and World Report, Jun. 1994, 68-78.
Hilfenhaus, J., et al., "A strategy for testing established human plasma protein manufacturing procedures for the ability to inactivate or eliminate human immunodeficiency virus" J. Bio. Stand 15:251-263 (1987).
Horowitz, B., et al., "Inactivation of viruses in labile blood derivatives" Transfusion 25:516-522 (1985).
Moroff, G., et al., "The influence of irradiation on stored platelets" Transufion 25:453-456 (1986).
Proudouz, K. N., et al., "Use of Laser-UV for inactivation of virus in blood products", Blood vol. 70:2 pp. 589-592, (1987).
Wagner, S. J., et al., "Red cell alterations associated with virucidal methylene blue phototreatment", Transfusion 33:30-36 (1993).
Bruisten, S. M., et al., "Efficiency of white cell filtration and a freeze-thaw procedure for removal of HIV-infected cells from blood", Transfusion 30:833 (1990).
Winslow, R. M., "Red cell substitutes: Current status, 1992" Nance, S. M., editor, Blood Safety: Current Challenges AABB pp. 151-167 (1992).
Gravitt, G. L., et al., "DNA-directed alkylating agents. 4. 4--anilinoquinoline--based minor groove directed aniline mustards" J. Med. Chem 34:1552-1560 (1991).
Cummings, J., et al., "Determination of reactive nitrogen mustard anti-cancer drugs in plasma by high-performance liquid chromatography using derivatization", Anal. Chem. 63:1514 (1991).
Maron, D. M., et al., "Revised methods for the salmonella mutagenicity test" Mutation Research 113:173-215 (1983).
Lin, L., et al., "Use of 8--Metboxypsoralen and long-wavelength ultraviolet radiation for decontamination of platelet concentrates" Blood 74:1 pp. 517-525 (1989).
Ganem, D., et al., "The molecular biology of the Hepatitis B viruses" Ann. Rev. Biochem. 56:651-693 (1987).
Hanson, C. V., et al, "Application of a Rapid microplaque assay for determination of HIV neutralizing antibody titers", J. Clin. Microbio. 28:9 pp. 2030-2034 (1990).
Wilson, W. R. et al., Patent No. WO94/27954 "Nitrobenzyl Mustard Quaternary Salts and their use as Hypoxia-selective cytotoxic agents", Filing date 24 May 1994.
LoGrippo, G. A. et al., "Chemical and combined methods for plasma sterilization , 6th Congress of the International Society of Blood Transfusion"; Hollander, editor pp. 225-230 (1958).
Mattes, W. B., et al., "GC-rich regions in genomes as target for DNA alkylation", Carcinogenesis vol. 9 No. 11, pp. 2065-2072 (1988).
Cook David
Nerio Aileen
Wollowitz Susan
Carroll Peter G.
Owens Amelia
Steritech, Inc.
Wilke Kathryn P.
LandOfFree
Treating red blood cell solutions with anti-viral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating red blood cell solutions with anti-viral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating red blood cell solutions with anti-viral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1929599